Delivery Order SPE2DB24D2205-SPE2DB25FEGJU
Award Date 8/18/25
Potential Completion Date 8/19/25
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,239.14 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This non-competitive, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and federal healthcare settings for immunization programs across the...
- The Defense Logistics Agency awarded a $19,926.00 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used across military medical treatment facilities and veteran healthcare systems to support immunization...
- The Defense Logistics Agency awarded a delivery order valued at $1,334.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes under a firm fixed price contract. This non-set-aside award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,498.00 to supply ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and veteran healthcare settings, aligning with the Department of...
- The Defense Logistics Agency awarded a delivery order valued at $2,713.02 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to federal healthcare systems. The contract was executed on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,124.45 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 ml syringes on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in pediatric immunization...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (20 micrograms per milliliter syringes). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,762.52 to AmerisourceBergen Drug Corp for Engerix-B 20 mcg/mL syringes. This competitive, non-set-aside contract was finalized on July 31, 2025, with completion scheduled for August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Engerix-B is a hepatitis B vaccine used extensively across military and federal healthcare systems to maintain immunization readiness among service...
- The Defense Logistics Agency awarded a $28,321.00 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of July 30, 2025. This competitive, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...